Lung Pulmonary Airway Disease Treatment Market to See Incredible Growth During2017-2027

Press Release

Lung (Pulmonary) Airway Disease affects the airways that transports oxygen and other gases in and out of the lungs. The Lung (Pulmonary) Airway Disease narrow down or block the airways. Such breathing problems caused due to Lung (Pulmonary) Airway Disease may inhibit the body receiving sufficient oxygen. Lung (Pulmonary) Airway Disease include bronchiectasis, asthma and COPD. People affected with Lung (Pulmonary) Airway Disease often feel as if they are breathing out through a straw. In Respiratory subdivision of NHLI, the Lung (Pulmonary) Airway Disease shares a prominent share and it affects significant population in Europe. Chronic obstructive pulmonary disease (COPD) is a kind of obstructive lung disease that affects the airflow for a longer time period with shortness of breath and sputum production.

Global Lung (Pulmonary) Airway Disease Treatment Market: Dynamics

The key driver to the Lung (Pulmonary) Airway Disease treatment market is the rising prevalence of respiratory diseases such as asthma, cystic fibrosis and COPD is increasing significantly across the world and.This is primarily because elderly people are highly susceptible to respiratory diseases (COPD, asthma, emphysema) due to reduced immunity and blood flow. Furthermore, introduction of advanced imaging technologies such as digital radiography and computed radiography are other major drivers of the market, this is because these technologies render high quality digital images. Digital imaging systems have witnessed low adoption rate as these are more expensive than analog imaging systems, this can restrain the Lung (Pulmonary) Airway Disease treatment market.

Download Sample Copy at

Global Lung (Pulmonary) Airway Disease Treatment Market: Segmentation

On the basis of Type, the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into, Asthma
Chronic Obstructive Pulmonary Disorder

On the basis of treatment the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into Bronchodilators
Cytotoxic Drugs
Oxygen Therapy

On the basis of end-user the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into, Hospitals
Rehabilitation Centers

Download Table of Contents at

On the basis of Region, the Global Lung (Pulmonary) Airway Disease Treatment market can be segmented into, North America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Latin America
Middle East & Africa

Global Lung (Pulmonary) Airway Disease Treatment Market: Region-wise Outlook

Geographically, North America was the largest market for Lung (Pulmonary) Airway Disease Treatment and the region is anticipated to maintain its dominance during the forecast period. Dominance of North America was due to increasing prevalence of respiratory diseases, risingpopularity of portable devices, and growing demand for home health care devices and services. The American Lung Association states that COPD is the third leading cause of death in the U.S. Moreover, rising demand for technologically advanced and innovative products in hospitals, diagnostic laboratories, and outpatient ambulatory surgery centers would fuel market growth in the region. Europe accounted for the second largest share of the global Lung (Pulmonary) Airway Disease Treatment market. However, Asia-Pacific is expected to expand at the highest CAGR during 2016-2024. This growth is mainly attributed to factors such as untapped opportunities, improving health care infrastructure, and increasing awareness about available diagnosticprocedures. Rapidly increasing number of hospitals is leading to higher demand for imaging technologies in hospital and laboratory settings, thereby driving the Lung (Pulmonary) Airway Disease Treatment market. Furthermore, the Lung (Pulmonary) Airway Disease Treatment market in Latin America is likely to expand at a significant CAGR. Brazil and Mexico are driving the Lung (Pulmonary) Airway Disease Treatment market in the region due to favorable initiatives taken by the respective governments. Moreover, rising health care infrastructure would fuel market growth in LatinAmerica.

Global Lung (Pulmonary) Airway Disease Treatment Market: Key Players

Currently, the global Lung (Pulmonary) Airway Disease Treatmentmarket is highly competitive owing to the involvement of   many established players. Some of the key players in the global Lung (Pulmonary) Airway Disease Treatmentmarket are Holaira,Inc., VIDA Diagnostics, Boehringer Ingelheim International GmBH,AstraZeneca, Teva Pharmaceuticals, GlaxoSmithKline and Novartis. The report covers exhaust analysis on: Market Segments Market Dynamics Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies involved Technology Value Chain The regional analysis includes: North America (U.S., Canada) Latin America (Mexico. Brazil) Western Europe (Germany, Italy, France, U.K, Spain) Eastern Europe (Poland, Russia) Asia-Pacific (China, India, ASEAN, Australia & New Zealand) Japan The Middle East and Africa (GCC Countries, S. Africa, Northern Africa) The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Report Highlights: Detailed overview of parent market Changing market dynamics in the industry In-depth market segmentation Historical, current and projected market size in terms of volume and value Recent industry trends and developments Competitive landscape Strategies of key players and products offered Potential and niche segments, geographical regions exhibiting promising growth A neutral perspective on market performance Must-have information for market players to sustain and enhance their market footprint.

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Request Customization for this report at